MTNR1B rs10830963: What Your Genotype Means for Glucose
The rs10830963 variant in the MTNR1B gene is a well-studied genetic marker associated with variations in fasting blood glucose levels and the risk of developing type 2 diabetes. By influencing how the body responds to melatonin, this common genetic change offers insight into the complex relationship between sleep-related hormone signaling and metabolic health.
What each genotype means
Lower fasting glucose risk
This genotype is associated with lower fasting blood glucose levels and a lower risk of type 2 diabetes compared to carriers of the G allele. Research suggests this genotype is linked to more typical insulin secretion patterns. Please discuss any concerns regarding your blood glucose levels or metabolic health with your clinician.
This genotype is common, found in approximately 49% of individuals in many global populations.
Intermediate glucose risk profile
Carrying one copy of the G allele is associated with a modest increase in fasting blood glucose levels and a slightly higher risk of type 2 diabetes. Studies indicate that this variant may influence how melatonin signaling affects insulin secretion from the pancreas. Please discuss your metabolic health and any dietary or lifestyle factors with your clinician.
This genotype is carried by roughly 42% of people globally.
Higher fasting glucose risk
This genotype is associated with higher fasting blood glucose levels and an increased risk of type 2 diabetes. Research suggests that the G allele may lead to increased expression of the melatonin receptor in the pancreas, which can impair early insulin secretion, particularly when melatonin levels are high. Please discuss your metabolic health and any concerns about glucose regulation with your clinician.
This genotype is carried by approximately 9% of the global population.
Understanding the rs10830963 SNP
The term SNP, or single nucleotide polymorphism, refers to a variation at a single position in a DNA sequence. In the case of rs10830963, the variation occurs within the MTNR1B gene, which provides instructions for making a protein called the melatonin receptor 1B. Located on chromosome 11, this specific site can hold either a cytosine (C) or a guanine (G) base. Because this variant is situated in a non-coding region of the gene—specifically in an intron—it does not change the structure of the melatonin receptor protein itself. Instead, research suggests that this variation may influence the amount of receptor protein produced or the timing of its expression. While often studied in the context of metabolic traits, rs10830963 serves as a classic example of how non-coding genetic variations can still exert measurable effects on human physiology by altering the regulation of gene activity.
The Role of the MTNR1B Gene
The MTNR1B gene is responsible for creating the Melatonin Receptor 1B, one of two primary receptors that allow the body to respond to melatonin. Melatonin is a hormone produced by the pineal gland, often called the hormone of darkness, as its production increases in the evening to signal to the body that it is time to sleep. These receptors are found in various tissues throughout the body, including the retina, the brain, and, importantly, the insulin-producing beta cells of the pancreas. When melatonin binds to these receptors, it can inhibit the release of insulin. Because insulin is the primary hormone responsible for lowering blood sugar levels, the signaling pathway governed by MTNR1B acts as a regulatory brake on insulin secretion. Understanding this gene is essential because it highlights the direct molecular link between our internal circadian rhythms—the biological processes that follow a 24-hour cycle—and the regulation of blood glucose.
Research and Metabolic Associations
The rs10830963 variant has been extensively investigated in the GWAS Catalog and numerous studies for its statistical association with fasting plasma glucose levels. The G allele of this SNP is widely considered the risk allele; individuals carrying this variant often show slightly higher fasting glucose levels and a statistically increased risk of type 2 diabetes compared to those with the C allele. This association is believed to stem from increased expression of the melatonin receptor in pancreatic beta cells, which may lead to excessive suppression of insulin secretion. However, the evidence strength for this association is categorized as moderate. While the genetic effect is consistent, it represents only one small piece of a much larger metabolic puzzle that includes diet, physical activity, body weight, and hundreds of other genetic markers. Therefore, while rs10830963 is a significant finding in genetic research, it should not be viewed as a standalone predictor of health outcomes.
Managing Your Genetic Information
It is important to remember that genetic associations are statistical, not deterministic. Knowing your genotype for rs10830963 does not provide a medical diagnosis or a roadmap for your future health. Because this variant is linked to blood glucose regulation, individuals may feel inclined to change their diet or lifestyle. However, it is always recommended that you discuss any health concerns, such as blood sugar management or metabolic health, with a qualified healthcare provider. They can interpret this information alongside standard clinical measurements like hemoglobin A1c, fasting glucose tests, and physical examinations. Do not use this genetic information to make decisions about medications or dietary interventions without professional guidance. Your genetics are only one factor in your overall health, and clinical tools remain the most accurate way to assess your current metabolic status and determine the best path forward for your long-term wellness.
How common is this variant?
The rs10830963 variant is highly prevalent across diverse human populations, with the G allele occurring at a frequency of approximately 30% globally.
Frequently asked questions
Can I use a DNA test to diagnose diabetes?
No, a genetic test cannot diagnose diabetes or prediabetes. Diabetes is a complex condition diagnosed through clinical blood tests, such as fasting plasma glucose or HbA1c, interpreted by a physician.
Does this SNP mean I will definitely develop diabetes?
No. Having a specific genotype at rs10830963 only indicates a statistical association with a trait, not a guarantee of disease. Many people with the higher-attention genotype do not develop diabetes, while those with the favorable genotype still can.
How does melatonin affect my blood sugar?
Melatonin signaling can inhibit insulin release from the pancreas. Variations in the MTNR1B gene may make some individuals more sensitive to this effect, potentially influencing fasting glucose levels.
Should I stop taking melatonin supplements because of this gene?
If you have concerns about how supplements might affect your metabolic health, discuss them with your doctor or pharmacist. They can provide advice based on your full medical history and current health status.
Sources & further reading
Educational information only, last refreshed 10/2/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs10830963?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in MTNR1B
Common upstream variant of the melatonin receptor type 1B affecting circadian melatonin signaling and sleep-glycemia coupling.
This variant is associated with increased fasting blood glucose levels and risk of type 2 diabetes.
This variant in the melatonin receptor 1B gene is significantly associated with REM sleep latency and the duration of melatonin secretion.